Generally healthy patients who undergo total hip replacement (THR) can be fast tracked to be discharged in two days compared with the standard three to six days, according to a new study by researchers at Hospital for Special ...
Jul 1, 2011
0
0
(HealthDay)—COVID-19 is associated with a high rate of pulmonary embolism, according to two research letters published online April 23 in Radiology.
Apr 28, 2020
0
1
Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous ...
Aug 17, 2011
0
0
Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood ...
Feb 7, 2012
0
0
COVID-19 typically presents as a respiratory illness, but cardiovascular complications such as irregular heartbeat (arrhythmia), lack of blood flow to the brain (stroke) and heart failure are also reported in some patients. ...
Feb 13, 2023
0
15
Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S. indicates the agents do not appear to be ...
May 16, 2011
0
0
Researchers from Boston University School of Medicine (BUSM) have found that computed tomography pulmonary angiography (CTPA), meant to improve detection of life-threatening pulmonary embolisms (PE), has led to over-diagnosis ...
May 9, 2011
0
0
(AP) -- New advice for pregnant women: If you're getting a C-section, special inflating boots strapped on your legs may lower the risk of a blood clot.
Aug 29, 2011
0
0
Being tall and obese may increase your risk for potentially dangerous blood clots, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
Apr 28, 2011
0
0
(HealthDay)—A safety clinical trial has revealed that tofacitinib (Xeljanz, Xeljanz XR) 10 mg twice daily is associated with an increased risk for pulmonary embolism (PE) and death among patients with rheumatoid arthritis ...
Mar 1, 2019
0
5
